Clinical Trial 48862

Overland Park, KS 66211


Summary:

Seeking individuals with a diagnosis of Stage 2, 3 or 4 COPD, Idiopathic Pulmonary Fibrosis or a cardiac rhythm disorder: Atrial Fibrilation, Bi/Tri/Quadrigeminy, Bradycardia or PVCs/PACs  to participate in a study that takes approximately 5 hours to complete while collecting data using devices. 

There is no investigational medication used for this study.  Those with COPD may be eligible to continue the study for a portion that collects data while the participant carries on their daily activities.  The take home portion lasts for up to 14 days. 



Requirements (at the time of screening):

  • Diagnosed with Stage 2, 3 or 4 COPD, Idiopathic Pulmonary Fibrosis OR
  • Cardiac arrhythmia noted on ECG during the screening visit
  • COPD participants must provide a Pulmonary Function Test (PFT) result taken within the last 5 years
  • Must have and be able to use all fingers (excluding thumbs)
  • No hand tremors
  • Must be able to provide documentation of full vaccination status for COVID
  • Pacemaker or AICD are exclusion criteria


Qualified Participants May Receive:

Up to $425 for the in-clinic portion of the study, and up to $2,000 for the at-home portion of the study - COPD subjects only.


Available At:

Iqvia - ECD Clinic
6700 W 115th Street
Overland Park, KS 66211
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.